NANOVIRICIDES, INC. Amortization of Deferred Loan Origination Fees, Net
NANOVIRICIDES, INC. (NNVC) reported Amortization of Deferred Loan Origination Fees, Net of -$1.64 thousand for the 6-month period ending 2019-12-31, per its 10-Q filed 2020-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredLoanOriginationFeesNet · last filed 2020-02-14
- 2019-12-31: Amortization of Deferred Loan Origination Fees, Net 6 month -$1.64K.
- 2018-12-31: Amortization of Deferred Loan Origination Fees, Net 6 month $0.00.
| Period end | Amortization of Deferred Loan Origination Fees, Net 6 month |
|---|---|
| 2019-12-31 | -$1.64K 10-Q · filed 2020-02-14 |
| 2018-12-31 | $0.00 10-Q · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |